Vertex Pharmaceuticals Stock News

Related Stocks: SBAC , VRTX , REGN , HUM , SAIC , FIS , STT , TFC , TNET , CASH , CVLT , SWIR , ATVI , AZO , AKAM , BJ , SYY , ZBRA , QTS , OTEX , ZNGA , HAE , STRA , CLDR ,

Vertex (VRTX) reported earnings 30 days ago. What's next for the stock?

This article was originally published on TipRanks.com Shares of Vertex Pharmaceuticals Incorporated (VRTX) jumped 9. The post Vertex Reveals Results from Phase 2 Study of VX-147; Shares Jump appeared first on Smarter Analyst .

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?

The ARK Invest founder might regret selling shares of these growth stocks.

The stock price of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) increased by over 8% during intraday trading today. This is why it happened.

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) claimed its second early-stage win after announcing positive results in a small study of VX-147 on a genetically defined form of chronic kidney di

Kymera's Protein Degrader Platform Tech Moves Forward With 3rd Candidate; Updated Data On KT-474 In December At R&D Day

Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead. The post 7 Drug Stocks to Buy Now While They're Still on Sale appe

All the elements are in place for a rebound.

Scout Investments Inc. raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 50.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 246,373 shares of the pharmaceutical companys stock after purchasing an additional 82,519 shares during the quarter. Scout Investments Inc.s []

Altfest L J & Co. Inc. increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 65.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,961 shares of the pharmaceutical companys stock after buying an additional 1,170 shares during the []

Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom line also exceeded Wall Streets projection amid a 29% growth [] The post Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook first appeared on AlphaStreet .

CRISPR's Life-Saving Technology Has Massive Potential